Cagri-Sema Blend
A combined amylin-and-GLP-1 preparation studied in metabolic research.
Overview
The Cagri-Sema blend combines Cagrilintide, an amylin analog, with Semaglutide, a GLP-1 receptor agonist, in a single preparation. In research literature the two mechanisms are studied together in the context of appetite-regulation and metabolic pathways. Each component is a well-characterized compound in the metabolic research category on its own.
Referenced research ranges
0.5–2.4 mg, once weekly — research protocols reference gradual titration and vary by component ratio
Reconstitution default
10 mg of total blend in 2 mL yields 5 mg/mL; a 2.5 mg reference draw is 0.5 mL (50 units on a U-100 syringe).
Storage
Store lyophilized vials refrigerated; refrigerate after reconstitution and protect from light.
Considerations
- Combines two mechanistically distinct compounds in one preparation.
- Blend ratios differ between preparations, so per-component amounts depend on the specific vial.
- Reconstituted peptide is temperature-sensitive and light-sensitive.
Log doses, get reminders, and run the calculator in PepSensei.
PepSensei is an educational reference tool only. Nothing in this library is medical advice, and none of it is intended to diagnose, treat, cure, or prevent any condition. All figures — including dose ranges, half-lives, and reconstitution examples — are commonly-cited values drawn from published research literature and are provided strictly for reference and general education in a research context. They are not protocols, recommendations, or instructions. Always consult a licensed medical professional before making any decision related to your health.